Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
Article ID | PMID | Source | Title | Publish Year | |
---|---|---|---|---|---|
A24237 | 23089687 | J Formos Med Assoc | Non-alcoholic fatty liver disease: an emerging liver disease in Taiwan. | 2012 | Details |
A24238 | 23087748 | Hepat Mon | Effects of metformin, pioglitazone, and silymarin treatment on non-alcoholic Fatty liver disease: a randomized controlled pilot study. | 2012 | Details |
A24239 | 23087670 | Front Neurol | Obstructive sleep apnea and non-alcoholic Fatty liver disease: is the liver another target? | 2012 | Details |
A24240 | 23085576 | Eur J Gastroenterol Hepatol | Evaluation of early atherosclerosis markers in patients with nonalcoholic fatty liver disease. | 2013 | Details |
A24241 | 23085575 | Eur J Gastroenterol Hepatol | Peripheral intrahepatic cholangiocarcinoma occurring in patients without cirrhosis or chronic bile duct diseases: epidemiology and histopathology of distant nontumoral liver in 57 White patients. | 2013 | Details |
A24242 | 23085008 | Biochim Biophys Acta | Dietary eicosapentaenoic acid supplementation accentuates hepatic triglyceride accumulation in mice with impaired fatty acid oxidation capacity. | 2012 | Details |
A24243 | 23084707 | J Pediatr | Increasing prevalence of nonalcoholic fatty liver disease among United States adolescents, 1988-1994 to 2007-2010. | 2012 | Details |
A24244 | 23084643 | Nutr Res | Resveratrol up-regulates hepatic uncoupling protein 2 and prevents development of nonalcoholic fatty liver disease in rats fed a high-fat diet. | 2012 | Details |
A24245 | 23081825 | Hepatology | Aging promotes the development of diet-induced murine steatohepatitis but not steatosis. | 2013 | Details |
A24246 | 23078220 | Can J Physiol Pharmacol | Endurance exercise in a rat model of metabolic syndrome. | 2012 | Details |
A24247 | 23078137 | Eur J Clin Invest | Nonalcoholic fatty liver disease in subjects with adrenal incidentaloma. | 2012 | Details |
A24248 | 23077931 | Rev Med Chir Soc Med Nat Iasi | The central role of the non alcoholic fatty liver disease in metabolic syndrome. | 2012 | Details |
A24249 | 23077135 | Gut | Whole-body substrate metabolism is associated with disease severity in patients with non-alcoholic fatty liver disease. | 2012 | Details |
A24250 | 23075940 | Curr Opin Clin Nutr Metab Care | Vitamin E and nonalcoholic fatty liver disease. | 2012 | Details |
A24251 | 23075296 | Ital J Pediatr | Therapeutic options in pediatric non alcoholic fatty liver disease: current status and future directions. | 2012 | Details |
A24252 | 23073195 | Zhong Xi Yi Jie He Xue Bao | [Comparative study on the effects of different therapeutic methods in preventing and treating nonalcoholic fatty liver in rats]. | 2012 | Details |
A24253 | 23071592 | PLoS One | Gene expression profiling unravels cancer-related hepatic molecular signatures in steatohepatitis but not in steatosis. | 2012 | Details |
A24254 | 23071295 | J Lipid Res | CCN1 expression in hepatocytes contributes to macrophage infiltration in nonalcoholic fatty liver disease in mice. | 2012 | Details |
A24256 | 23070083 | J Physiol Pharmacol | A novel pathophysiological-based panel of biomarkers for the diagnosis of nonalcoholic steatohepatitis. | 2012 | Details |
A24257 | 23069937 | Lab Invest | Steatosis does not impair liver regeneration after partial hepatectomy. | 2012 | Details |
A24259 | 23068074 | Mol Aspects Med | Innate immune activation in obesity. | 2012 | Details |
A24260 | 23067270 | Hepatol Res | Serum biomarkers in type 2 diabetic patients with non-alcoholic steatohepatitis and advanced fibrosis. | 2012 | Details |
A24261 | 23066946 | Aliment Pharmacol Ther | Assessment of non-alcoholic fatty liver disease using serum total cell death and apoptosis markers. | 2012 | Details |
A24262 | 23066331 | World J Gastroenterol | Vague relationship between alcohol consumption and metabolic syndrome in nonobese people. | 2012 | Details |
A24263 | 23066121 | J Clin Endocrinol Metab | Increased fetuin-A concentrations in impaired glucose tolerance with or without nonalcoholic fatty liver disease, but not impaired fasting glucose. | 2012 | Details |
A24264 | 23066040 | Cancer Res | Paracrine Hedgehog signaling drives metabolic changes in hepatocellular carcinoma. | 2012 | Details |
A24265 | 23066023 | J Biol Chem | Kuppfer cells trigger nonalcoholic steatohepatitis development in diet-induced mouse model through tumor necrosis factor-α production. | 2012 | Details |
A24266 | 23065020 | J Gastroenterol | The effect of etanercept on hepatic fibrosis risk in patients with non-alcoholic fatty liver disease, metabolic syndrome, and psoriasis. | 2012 | Details |
A24267 | 23063693 | Biochimie | A systems biology approach to the hepatic role of the oxysterol receptor LXR in the regulation of lipogenesis highlights a cross-talk with PPARα. | 2012 | Details |
A24270 | 23062376 | Ultrasound Med Biol | Ex vivo study of quantitative ultrasound parameters in fatty rabbit livers. | 2012 | Details |
A24271 | 23061759 | Clin Transplant | Recurrence of non-alcoholic steatohepatitis and cryptogenic cirrhosis following orthotopic liver transplantation in the context of the metabolic syndrome. | 2013 | Details |
A24272 | 23060397 | Hepatobiliary Pancreat Dis Int | Serum parameters predict the severity of ultrasonographic findings in non-alcoholic fatty liver disease. | 2012 | Details |
A24273 | 23059409 | J Clin Gastroenterol | Hepatic steatosis in human immunodeficiency virus: a prospective study in patients without viral hepatitis, diabetes, or alcohol abuse. | 2013 | Details |
A24274 | 23059407 | J Clin Gastroenterol | Primary biliary cirrhosis is more severe in overweight patients. | 2013 | Details |
A24275 | 23057494 | Aliment Pharmacol Ther | Review article: the emerging interplay among the gastrointestinal tract, bile acids and incretins in the pathogenesis of diabetes and non-alcoholic fatty liver disease. | 2012 | Details |
A24276 | 23055155 | Hepatology | Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH. | 2013 | Details |
A24277 | 23054903 | J Gastrointest Surg | Metabolic disorders, non-alcoholic fatty liver disease and major liver resection: an underestimated perioperative risk. | 2012 | Details |
A24278 | 23044079 | Dig Liver Dis | The pro-inflammatory action of tumour necrosis factor-α in non-alcoholic steatohepatitis is independent of the NSMAF gene product. | 2012 | Details |
A24279 | 23042833 | Nutr Clin Pract | Anthropometric measures of visceral and subcutaneous fat are important in the determination of metabolic dysregulation in boys and girls at risk for nonalcoholic fatty liver disease. | 2012 | Details |
A24280 | 23042597 | Proteins | Molecular dynamics simulation of PNPLA3 I148M polymorphism reveals reduced substrate access to the catalytic cavity. | 2012 | Details |
A24281 | 23042372 | Minerva Med | Circulating resistin is elevated in patients with non-alcoholic fatty liver disease and is associated with steatosis, portal inflammation, insulin resistance and nonalcoholic steatohepatitis scores. | 2012 | Details |
A24282 | 23041539 | Clin Gastroenterol Hepatol | Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review. | 2012 | Details |
A24283 | 23041327 | Gastroenterology | The cholesterol derivative 27-hydroxycholesterol reduces steatohepatitis in mice. | 2012 | Details |
A24284 | 23040432 | Can J Cardiol | Association between nonalcoholic fatty liver disease and cardiovascular risk in obese children and adolescents. | 2012 | Details |
A24286 | 23038002 | J Toxicol Sci | Hepatoprotective effect of tamoxifen on steatosis and non-alcoholic steatohepatitis in mouse models. | 2012 | Details |
A24287 | 23037628 | J Clin Exp Hematop | Rapidly progressing fatal adult multi-organ Langerhans cell histiocytosis complicated with fatty liver disease. | 2012 | Details |
A24288 | 23036645 | Metabolism | Elevated serum uric acid levels are associated with non-alcoholic fatty liver disease independently of metabolic syndrome features in the United States: Liver ultrasound data from the National Health and Nutrition Examination Survey. | 2012 | Details |
A24289 | 23036186 | Dig Liver Dis | A new approach to facilitate diagnosis of nonalcoholic fatty liver disease through a galactose single point method in rats with fatty liver. | 2012 | Details |
A24290 | 23034128 | J Gastroenterol Hepatol | Treatment of non-alcoholic steatohepatitis with Phyllanthus urinaria: a randomized trial. | 2013 | Details |
A24292 | 23032985 | Am J Gastroenterol | The interaction of rs738409, obesity, and alcohol: a population-based autopsy study. | 2012 | Details |
A24293 | 23032980 | Am J Gastroenterol | Association of nonalcoholic fatty liver disease with components of metabolic syndrome according to body mass index in Korean adults. | 2012 | Details |
A24294 | 23032979 | Am J Gastroenterol | Liver stiffness measurement using XL probe in patients with nonalcoholic fatty liver disease. | 2012 | Details |
A24295 | 23031808 | Gene | Association of peroxisome proliferator activated receptor-γ gene with non-alcoholic fatty liver disease in Asian Indians residing in north India. | 2012 | Details |
A24296 | 23028811 | PLoS One | Glucose intolerance and the amount of visceral adipose tissue contribute to an increase in circulating triglyceride concentrations in Caucasian obese females. | 2012 | Details |
A24297 | 23028489 | PLoS One | Metabolomic profiling to identify predictors of response to vitamin E for non-alcoholic steatohepatitis (NASH). | 2012 | Details |
A24298 | 23028442 | PLoS One | Metformin prevents and reverses inflammation in a non-diabetic mouse model of nonalcoholic steatohepatitis. | 2012 | Details |
A24299 | 23026700 | Food Chem Toxicol | Cassia tora (Leguminosae) seed extract alleviates high-fat diet-induced nonalcoholic fatty liver. | 2012 | Details |
A24300 | 23026517 | Biomed Environ Sci | The prevalence of nonalcoholic fatty liver disease and its association with lifestyle/dietary habits among university faculty and staff in Chengdu. | 2012 | Details |
A24301 | 23025244 | J Med Chem | Synthesis and biological evaluation of 5-benzylidenepyrimidine-2,4,6(1H,3H,5H)-trione derivatives for the treatment of obesity-related nonalcoholic fatty liver disease. | 2012 | Details |
A24302 | 23024085 | Indian Pediatr | Non-alcoholic fatty liver disease in children. | 2012 | Details |
A24303 | 23023916 | Magn Reson Med | In vivo (1)H-MRS hepatic lipid profiling in nonalcoholic fatty liver disease: an animal study at 9.4 T. | 2012 | Details |
A24304 | 23023705 | J Clin Invest | Chronic overexpression of PNPLA3I148M in mouse liver causes hepatic steatosis. | 2012 | Details |
A24305 | 23022698 | Clin Gastroenterol Hepatol | Association between anthropometric parameters and measurements of liver stiffness by transient elastography. | 2012 | Details |
A24306 | 23022226 | Biochem Pharmacol | High-carbohydrate diets induce hepatic insulin resistance to protect the liver from substrate overload. | 2012 | Details |
A24307 | 26181068 | Clin J Gastroenterol | Nonalcoholic fatty liver disease: from lipid profile to treatment. | 2012 | Details |
A24308 | 24834224 | Gastroenterol Hepatol Bed Bench | Assessment of NAFLD cases and its correlation to BMI and metabolic syndrome in healthy blood donors in Kerman. | 2012 | Details |
A24309 | 24683373 | Gastroenterol Hepatol (N Y) | Noninvasive Diagnosis of NASH and Liver Fibrosis Within the Spectrum of NAFLD. | 2012 | Details |
A24310 | 23018041 | Nutr Metab Cardiovasc Dis | Arterial function and structure after a 1-year lifestyle intervention in children with nonalcoholic fatty liver disease. | 2012 | Details |
A24311 | 23014486 | J Nutr | Opuntia ficus indica (nopal) attenuates hepatic steatosis and oxidative stress in obese Zucker (fa/fa) rats. | 2012 | Details |
A24312 | 23012671 | J Gastrointestin Liver Dis | Is there any consensus as to what diet or lifestyle approach is the right one for NAFLD patients? | 2012 | Details |
A24313 | 23012396 | Physiol Genomics | Effects of perilipin 2 antisense oligonucleotide treatment on hepatic lipid metabolism and gene expression. | 2012 | Details |
A24314 | 23009757 | Eur Cytokine Netw | TNF-α messenger ribonucleic acid (mRNA) in patients with nonalcoholic steatohepatitis. | 2013 | Details |
A24316 | 23006461 | Saudi J Gastroenterol | Serum TGF-β, Serum MMP-1, and HOMA-IR as non-invasive predictors of fibrosis in Egyptian patients with NAFLD. | 2013 | Details |
A24317 | 23002334 | World J Gastroenterol | Interactions between hepatic iron and lipid metabolism with possible relevance to steatohepatitis. | 2012 | Details |
A24318 | 23001964 | Pediatr Obes | The potential role of fatty liver in paediatric metabolic syndrome: a distinct phenotype with high metabolic risk? | 2012 | Details |
A24319 | 23000435 | J Hepatol | Liver transplantation for hepatocellular carcinoma in a patient with a novel telomerase mutation and steatosis. | 2012 | Details |
A24320 | 23000278 | Appetite | Investigation of anthropometric, biochemical and dietary parameters of obese children with and without non-alcoholic fatty liver disease. | 2012 | Details |
A24321 | 22999829 | J Adolesc Health | Nonalcoholic fatty liver in children and adolescents: an overview. | 2012 | Details |
A24322 | 22999247 | Heart Fail Clin | Hepatic and cardiac steatosis: are they coupled? | 2012 | Details |
A24323 | 22999011 | Metabolism | In patients with non-alcoholic fatty liver disease, metabolically abnormal individuals are at a higher risk for mortality while metabolically normal individuals are not. | 2012 | Details |
A24324 | 22998508 | Clin Exp Pharmacol Physiol | Renal function-dependent association of serum uric acid with metabolic syndrome and hepatic fat content in a middle-aged and elderly Chinese population. | 2012 | Details |
A24325 | 22997912 | Ter Arkh | [Clinicopathogenetic characteristics of cardiorenal syndrome in non-alcoholic fatty liver disease]. | 2012 | Details |
A24326 | 22997724 | Klin Med (Mosk) | [Pathogenetic therapy of metabolic syndrome at the stage of visceral lesions]. | 2012 | Details |
A24327 | 22997020 | J Clin Ultrasound | Sonographic hepatorenal ratio: a noninvasive method to diagnose nonalcoholic steatosis. | 2012 | Details |
A24328 | 22996622 | Hepatology | Hepatic fat loss in advanced nonalcoholic steatohepatitis: are alterations in serum adiponectin the cause? | 2013 | Details |
A24329 | 22995553 | Dig Liver Dis | Serum osteopontin levels as a predictor of portal inflammation in patients with nonalcoholic fatty liver disease. | 2012 | Details |
A24331 | 22991207 | Physiol Genomics | Dietary fat source alters hepatic gene expression profile and determines the type of liver pathology in rats overfed via total enteral nutrition. | 2012 | Details |
A24332 | 22990555 | Rom J Morphol Embryol | Association between liver histology, carotid ultrasonography and retinal vascular changes in patients with nonalcoholic fatty liver disease (NAFLD). | 2012 | Details |
A24333 | 22989301 | J Gastroenterol Hepatol | Fatty liver reduces hepatitis B virus replication in a genotype B hepatitis B virus transgenic mice model. | 2012 | Details |
A24334 | 22989165 | J Gastroenterol Hepatol | Influence of non-alcoholic fatty liver disease on the development of diabetes mellitus. | 2013 | Details |
A24335 | 22988926 | J Dig Dis | Inhibitory effect of Ginkgo biloba extract on fatty liver: regulation of carnitine palmitoyltransferase 1a and fatty acid metabolism. | 2012 | Details |
A24337 | 22987396 | Hepatology | Toll-like receptor 2 and palmitic acid cooperatively contribute to the development of nonalcoholic steatohepatitis through inflammasome activation in mice. | 2013 | Details |
A24338 | 22986520 | Cardiology | The association between nonalcoholic fatty liver disease, metabolic syndrome and arterial stiffness in nondiabetic, nonhypertensive individuals. | 2012 | Details |
A24339 | 22986486 | Endocr J | Essential roles of growth hormone (GH) and insulin-like growth factor-I (IGF-I) in the liver. | 2012 | Details |
A24341 | 22985537 | Clin Chim Acta | Identification of a support vector machine-based biomarker panel with high sensitivity and specificity for nonalcoholic steatohepatitis. | 2012 | Details |
A24342 | 22983378 | J Pediatr Gastroenterol Nutr | Serum retinol-binding protein 4 is independently associated with pediatric NAFLD and fasting triglyceride level. | 2013 | Details |
A24343 | 22982943 | Gastroenterology | Sterile inflammation in the liver. | 2012 | Details |
A24344 | 22982377 | FASEB J | A maternal high-fat diet modulates fetal SIRT1 histone and protein deacetylase activity in nonhuman primates. | 2012 | Details |
A24345 | 22981383 | Biochem Pharmacol | Endogenously synthesized n-3 polyunsaturated fatty acids in fat-1 mice ameliorate high-fat diet-induced non-alcoholic fatty liver disease. | 2012 | Details |
A24346 | 22980664 | Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi | [Expression of MCP-1 in the patients of chronic hepatitis B complicated with nonalcoholic fatty liver disease]. | 2012 | Details |